Xenova Strikes Deal With Eli Lilly

Shares in Xenova rose 16 per cent on Wednesday after the UK biotechnology business struck a partnership with Eli Lilly, the worlds eighth-largest pharmaceuticals company, to develop drugs to reduce the risk of blood clots. The US company will pay Xenova and MetaXen, a California biotech company in which Xenova has a 93 per cent stake, $35m (